A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions
| Autor: | Weiping Tang, Hongluan Wang, Ying Zhou, Fei Li, Li-Xia Xiong |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Pediatrics endocrine system Hepatosplenomegaly lymphoma Disease Review Malignancy hemophagocytic syndrome 03 medical and health sciences 0302 clinical medicine Internal medicine hemic and lymphatic diseases medicine Histiocyte Cytopenia Hemophagocytic lymphohistiocytosis Hematology business.industry fungi medicine.disease musculoskeletal system Oncology hemophagocytic lymphohistiocytosis 030220 oncology & carcinogenesis medicine.symptom Hemophagocytosis business hormones hormone substitutes and hormone antagonists 030215 immunology malignancy |
| Zdroj: | Oncotarget |
| ISSN: | 1949-2553 |
| Popis: | // Hongluan Wang 1, 2, 3, * , Lixia Xiong 1, 2, * , Weiping Tang 1, 2 , Ying Zhou 2 and Fei Li 1 1 Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China 2 Medical College, Nanchang University, Nanchang, Jiangxi 330006, China 3 Department of Respiratory, Jiangxi Provincial People’s Hospital, Nanchang, Jiangxi 330006, China * These authors contributed equally to this work Correspondence to: Fei Li, email: yx021021@sina.com Keywords: hemophagocytic lymphohistiocytosis, hemophagocytic syndrome, malignancy, lymphoma Received: May 17, 2017 Accepted: June 29, 2017 Published: July 14, 2017 ABSTRACT As an infrequent but potentially life-threatening hyperinflammatory syndrome, hemophagocytic lymphohistiocytosis (HLH) is clinically characterized with prolonged fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia, hyperferritinemia and hemophagocytosis in bone marrow, liver, spleen or lymph nodes. Malignancy-associated HLH (M-HLH), one type of acquired HLH, usually presents variable overlaps of symptoms with other types of HLH, thus resulting in higher incidence of misdiagnosis and mortality. In recent years, with the increasing awareness to this disease, the diagnosis and management of HLH have gained more and more attention, and improvements have been made accordingly. As a result, the survival of patients is greatly prolonged. However, there is still no consensus on the diagnostic criteria and treatment strategies due to lack of large samples or prospective clinical trials. In order to improve recognition and diagnosis, and provide guidance regarding the treatment of M-HLH, the Study Group in HLH Subtypes of the Histiocyte Society has developed consensus recommendations for the diagnosis and management of M-HLH in 2015. In the present article, we summarized and discussed some updated understandings in M-HLH. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|